STAT3 and prostate cancer: Cell line studies demonstrate that STAT3 activation results in an increase in proliferation and induces neuroendocrine differentiation, although out with the scope of the current study these parameters warrant further investigation in clinical tissue to establish the route by which STAT3 influences prostate cancer patient survival (Spiotto and Chung, 2000b).